Oscar Health Inc (NYSE: OSCR): Stock Forecast For 2024 Sees A An Incline Of 168.55%

EVTL

In today’s recent session, 0.78 million shares of the Oscar Health Inc (NYSE:OSCR) have been traded, and its beta is 1.67. Most recently the company’s share price was $15.71, and it changed around -$0.3 or -1.87% from the last close, which brings the market valuation of the company to $3.61B. OSCR at last check was trading at a discount to its 52-week high of $18.55, offering almost -18.08% off that amount. The share price’s 52-week low was $4.72, which indicates that the recent value has risen by an impressive 69.96% since then. We note from Oscar Health Inc’s average daily trading volume that its 3-month average coming to 3.16 million.

Oscar Health Inc (NYSE:OSCR) trade information

Instantly OSCR has been showing red trend so far today with a performance of -1.87% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently up 71.69% year-to-date, but still up 6.15% over the last five days. On the other hand, Oscar Health Inc (NYSE:OSCR) is 14.17% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $9.67, which translates to bulls needing to decrease their stock price by -62.46% from its current value. Analyst projections state that OSCR is forecast to be at a low of $4 and a high of $20.

Oscar Health Inc (OSCR) estimates and forecasts

Oscar Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 212.95 percent over the past six months and at a 81.15% annual growth rate that is well above the industry average of 13.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 250.00% in revenue this quarter, and will report an increase of 357.10% in the next quarter. The year-over-year growth rate is expected to be 42.20%, up from the previous year.

Consensus estimates provided by 3 financial analysts predict the company will bring in an average of $2.01 billion in revenue for the current quarter. 3 analysts expect Oscar Health Inc to make $2.1 billion in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $1.15 billion and $1.52 billion respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 75.50%. Forecasts for the next quarter put sales growth at 37.80%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.85%.